IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-5.26%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$329M
AUM Growth
+$329M
(-5.9%)
Cap. Flow
+$40M
Cap. Flow
% of AUM
12.16%
Top 10 Holdings %
Top 10 Hldgs %
37.77%
Holding
184
New
15
Increased
124
Reduced
12
Closed
9
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.52M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.34M |
| 5 |
BLU
BELLUS Health Inc.
BLU
|
$5.94M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$11.3M |
| 2 |
Biogen
BIIB
|
$6M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$5.89M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$3.95M |
| 5 |
iShares Biotechnology ETF
IBB
|
$3.67M |
Sector Composition
| 1 | Healthcare | 98.75% |
| 2 | Consumer Staples | 0.62% |
| 3 | Technology | 0.36% |
| 4 | Financials | 0.23% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
United Therapeutics
UTHR
$17.7B
| – | – |
0
| – | – |
|
177
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
DCPH
178
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
0
| – | – |
|
|
MRTX
179
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
0
| – | – |
|
|
TCDA
180
DELISTED
Tricida, Inc. Common Stock
TCDA
| – | – |
0
| – | – |
|
|
FLACU
181
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
| – | – |
-941
| Closed | -$9K |
|
|
ARNA
182
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-2,161
| Closed | -$200K |
|
|
ODT
183
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| – | – |
-1,340,631
| Closed | -$1.81M |
|
|
ZGNX
184
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
0
| – | – |
|